Search research articles
Contact Us
Filters
Showing results (381-390 of 1,168) with videos related to
Page
of 117
Sort By:
Annals of Hematology
|
May 18, 2023
Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry
David Dingli, Jaroslaw P Maciejewski, Loree Larratt, et al.
JAMA
|
June 2, 2021
Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges
Matthew D Solomon, Mai Nguyen-Huynh, Thomas K Leong, et al.
BMC Endocrine Disorders
|
February 21, 2020
Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study
Amer Budayr, Thida C Tan, Joan C Lo, et al.
Journal of the American Geriatrics Society
|
January 1, 2017
Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke
Emer R McGrath, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology
|
July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society
|
November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study
Jeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine
|
November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
Margaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study
Daniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
The American Journal of Cardiology
|
March 26, 2016
Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease
Ashok Krishnaswami, Anne C H Goh, Alan S Go, et al.
Plos One
|
November 1, 2023
CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
Sijie Zheng, Rishi V Parikh, Thida C Tan, et al.
Page
of 117
Search research articles
Search
Showing results (381-390 of 1,168) with videos related to
Sort By:
Page
of 117
Annals of Hematology
|
May 18, 2023
Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry
David Dingli, Jaroslaw P Maciejewski, Loree Larratt, et al.
JAMA
|
June 2, 2021
Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges
Matthew D Solomon, Mai Nguyen-Huynh, Thomas K Leong, et al.
BMC Endocrine Disorders
|
February 21, 2020
Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study
Amer Budayr, Thida C Tan, Joan C Lo, et al.
Journal of the American Geriatrics Society
|
January 1, 2017
Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke
Emer R McGrath, Alan S Go, Yuchiao Chang, et al.
Journal of the American College of Cardiology
|
July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Margaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society
|
November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study
Jeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine
|
November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
Margaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study
Daniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
The American Journal of Cardiology
|
March 26, 2016
Effectiveness of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With End-Stage Renal Disease
Ashok Krishnaswami, Anne C H Goh, Alan S Go, et al.
Plos One
|
November 1, 2023
CKD stage-specific utility of two equations for predicting 1-year risk of ESKD
Sijie Zheng, Rishi V Parikh, Thida C Tan, et al.
Page
of 117